Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145548 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of the Spiration IBV™ System
A Phase 2 study, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 91
- Enrollment target
NCT00145548 is a Phase 2 study that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 91 participants.
The verdict
NCT00145548, a Phase 2 study, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 91 participants
- Enrollment target
Study Summary
The Spiration Intra-Bronchial Valve is intended for use as a minimally invasive treatment for severe emphysema, using standard bronchoscopy. The valve is designed to limit airflow to a selected portion of the lung, producing a reduction in lung volume, which may improve pulmonary function in patients with emphysema.
Interventions
- DEVICE Intra Bronchial Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00145548
The ClinicalTrials.gov registry entry for NCT00145548 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra Bronchial Valve is the first listed.
NCT00145548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00145548 about?
NCT00145548 is a clinical study titled "Pilot Study of the Spiration IBV™ System". The Spiration Intra-Bronchial Valve is intended for use as a minimally invasive treatment for severe emphysema, using standard bronchoscopy. The valve is designed to limit airflow to a selected portion of the lung, producing a reduction in lung volume, which may improve pulmonary function in patient...
What is the current status of trial NCT00145548?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 91 participants. The study started on 2003-12. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00145548?
The interventions under investigation include: Intra Bronchial Valve (DEVICE).
Who is sponsoring clinical trial NCT00145548?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.